The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
Open accessAbstract
In addition to angioimmunoblastic T-cell lymphoma (AITL), the 2016 revised WHO classification of haematological malignancies recognizes two provisional lymphoma entities of follicular helper T-cell (TFH) derivation, namely follicular peripheral T-cell lymphoma (F-PTCL) and nodal PTCL with a TFH phenotype. Here, we performed a comprehensive, integrative clinicopathological and molecular analysis of these three entities. We found that F-PTCL and other nodal PTCL with TFH phenotype share not only immunophenotypical features, but also similar clinical, genetic and molecular features with AITL. Our results support the view that these lymphomas belong to the spectrum of a common disease. AITL and PTCL, not otherwise specified (PTCL-NOS), account for the majority of nodal PTCLs. While PTCLNOS is by definition heterogeneous and an exclusion diagnosis, AITL is characterized by a constellation of clinical, morphological, and immunophenotypical features, and defined by its cellular derivation from TFH cells. The typical pathological features, i.e., clear cells, increased vascularization, follicular dendritic cell (FDC) proliferation, and the presence of eosinophils, inflammatory cells, and EBV-positive B-blasts, are variably developed. An overlap between AITL and PTCL-NOS was substantiated by the observation that a subset of cases diagnosed as PTCL-NOS, upon routine pathological evaluation, actually harbor imprints of the TFH signature and/or express TFH-associated markers. Furthermore, the rare “follicular” T-cell lymphoma (F-PTCL), initially classified as a PTCL-NOS variant, is characterized by a TFH immunophenotype and clinicopathological features overlapping with AITL. Recently, recurrent AITL-associated TET2, DNMT3A and RHOA mutations were also found in a subset of PTCL-NOS, and tended to correlate with TFH features. Based on these recent findings, the 2016 update of the WHO classification groups AITL and other nodal lymphomas of TFH origin under the same umbrella. However, a thorough, systematic and multiparametric comparison of these entities is lacking. Here, we performed a comprehensive integrative clinicopathological and molecular analysis comparing AITL and other nodal PTCLs of TFH origin. Twenty-one such cases, including five F-PTCL, were identified in the TENOMIC biobank of the LYSA, and compared to 94 AITL and 36 PTCL-NOS. All cases were reviewed by three hematopathologists according to the 2016 WHO classification criteria ( and Online Supplementary Information). The five F-PTCL by definition comprised FDCs associated to the follicles without extrafollicular FDC expansion, and were positive for all TFH markers tested (4 or 5) (Figure 1A-B). The 16 other nodal PTCL with TFH phenotype (referred to as “TFH-like PTCL”) (Figure 1A, 1C, 1D) lacked typical morphological AITL
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Cited by
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. D. O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01620-2 · Cited by 4,004
Self-citationCampo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Self-citationGenetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Heavican, T. B., Bouska, A., Yu, J., Lone, W., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., et al. (2019) · Blood · doi:10.1182/blood-2018-09-872549 · Cited by 275
Self-citationHolst, J. M., Plesner, T. L., Pedersen, M. B., Frederiksen, H., Møller, M. B., Clausen, M. R., Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.225839 · Cited by 25
Metadata
- Authors
- Dobay, M. P., Lemonnier, F., Missiaglia, E., Bastard, C., Vallois, D., Jais, J.-P., Scourzic, L., Dupuy, A., Fataccioli, V., Pujals, A., Parrens, M., Le Bras, F., Rousset, T., Picquenot, J.-M., Martin, N., Haioun, C., Delarue, R., Bernard, O. A., Delorenzi, M., de Leval, L., & Gaulard, P.
- Venue
- Haematologica
- Published
- 2017-01-12
- Volume
- 102
- Issue
- 4
- Pages
- e148-e151
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2579636005
- Cited by
- 231
- References
- 1
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. https://app.cochat.ai/papers/10.3324/haematol.2016.158428
- The paper
- Dobay, M. P., Lemonnier, F., Missiaglia, E., Bastard, C., Vallois, D., Jais, J.-P., Scourzic, L., Dupuy, A., Fataccioli, V., Pujals, A., Parrens, M., Le Bras, F., Rousset, T., Picquenot, J.-M., Martin, N., Haioun, C., Delarue, R., Bernard, O. A., Delorenzi, M., . . . Gaulard, P. (2017). Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica. https://doi.org/10.3324/haematol.2016.158428
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.